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Quantitative Assessment of the T2
Relaxation Time of the Gluteus Muscles
in Children with Duchenne Muscular
Dystrophy: a Comparative Study Before
and After Steroid Treatment
Objective: To determine the feasibility of using T2 mapping as a quantitative
method to longitudinally follow the disease activity in children with Duchenne
muscular dystrophy (DMD) who are treated with steroids. 
Materials and Methods: Eleven boys with DMD (age range: 5-14 years)
underwent evaluation with the clinical functional score (CFS), and conventional
pelvic MRI and T2 mapping before and during steroid therapy. The gluteus mus-
cle inflammation and fatty infiltration were evaluated on conventional MRI. The
histograms and mean T2 relaxation times were obtained from the T2 maps. The
CFS, the conventional MRI findings and the T2 values were compared before
and during steroid therapy. 
Results: None of the patients showed interval change of their CFSs. On con-
ventional MRI, none of the images showed muscle inflammation. During steroid
treatment, two boys showed increased fatty infiltration on conventional MRI, and
both had an increase of the mean T2 relaxation time (p < 0.05). The remaining
nine boys had no increase in fatty infiltration. Of these, three showed an
increased mean T2 relaxation time (p < 0.05), two showed no change and four
showed a decreased mean T2 relaxation time (p < 0.05). 
Conclusion: T2 mapping is a feasible technique to evaluate the longitudinal
muscle changes in those children who receive steroid therapy for DMD. The dif-
ferences of the mean T2 relaxation time may reflect alterations in disease activity,
and even when the conventional MRI and CFS remain stable.
uchenne muscular dystrophy (DMD) is a fatal X-linked recessive
muscular dystrophy that affects approximately one in 3,500 boys (1). It is
characterized by progressive muscle weakness that starts in the pelvic
girdle and this spreads to the distal extremities. Disease progression ultimately results
in death, which often occurs during the 3rd decade (1). Steroid therapy can slow the
progression of muscle weakness by decreasing the inflammation, which is thought to
be an early process of the disease. However, steroid therapy is associated with long
term side effects (2-4). Thus, it is essential to monitor the progress of disease in these
children to determine the therapeutic effect. 
A clinical functional grading system to assess muscle strength by using the clinical
functional score (CFS) has been adapted from Swinyard et al. (5) as a practical method
to monitor the disease activity of patients with DMD. However, the CFS has limita-
tions for assessing an uncooperative child and for evaluating individual muscles in a
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Dgiven patient (6-8). Conventional magnetic resonance
imaging (MRI) has shown superior sensitivity for assess the
disease severity in patients with DMD, as compared to that
of CFS (9). However, the conventional MRI findings of
signal intensity changes that suggest muscle inflammation
and fatty infiltration are subjective, rather than being
objective or quantitative. 
T2 relaxation time mapping (T2 mapping) has been used
as an advanced technique to detect microarchitectural
changes in the articular cartilage and that occur with early
degeneration or inflammation (10, 11). However, there are
relatively few reports in the medical literature regarding
applications of T2 mapping for evaluating diseases of the
soft tissues, and specifically muscles (11, 12). A previous
study that used T2 mapping of the lower extremities in
patients with DMD showed an increased T2 relaxation
time of the fatty infiltration within muscles (12). Another
study that utilized T2 mapping of the lower extremity
muscles of patients with dermatomyositis showed an
increased T2 relaxation time of inflammation (13). These
prior studies used T2 mapping to evaluate a single time
point in a disease process. To the best of our knowledge,
there have been no longitudinal studies that have utilized
T2 mapping of the muscles, and none that have specifically
done so in children.
The purpose of our study was to determine the feasibility
of using T2 mapping as a quantitative method to follow the
longitudinal disease activity in children who are undergo-
ing steroid therapy for DMD. We performed T2 mapping
to identify any statistically significant quantitative changes
in the muscles prior to and during the course of steroid
treatment.
MATERIALS AND METHODS
This prospective study was approved by the Institutional
Review Board of our institution and written informed
consent was obtained from all participants’ parents or
guardians prior to enrollment. The patients diagnosed with
DMD and who presented to our institution from June 2006
to October 2008 were recruited. The inclusion criteria
were 1) the diagnosis of DMD was confirmed by genetic
analysis or muscle biopsy, 2) a CFS of no (value = 1) or
minimal (value = 2) muscle weakness and 3) they were
planned to undergo oral steroid (deflazacort) treatment.
Eleven boys (mean age: 8.5 years, age range: 5 to 14
years) were included in this study.
Clinical Assessment
All the enrolled children underwent clinical assessment
at two time points: prior to steroid treatment and during
the steroid treatment. The CFS was assessed by two
pediatric neurologists by consensus and they used the
Medical Research Council (MRC) scale with grading from 1
(normal) to 8 (severe dysfunction). The CFS was obtained
at the same visit when the MRI assessment was obtained.
Each patient started treatment with a 12-18 month course
of oral steroids (deflazacort) immediately after the clinical
assessment and the initial imaging assessment.
Imaging Assessment
Conventional MRI and T2 mapping were done prior to
and during a 12-18 month course of steroid treatment.
Twenty-two MRI studies were completed with a mean
interval of 14.6 months between the MRI examinations.
Conventional MRI
Conventional MRI was performed using a 1.5T imaging
system (12X HD Excite, GE Medical Systems, Milwaukee,
WI) with an 8 channel receive-only phased array cardiac
coil (USA Instruments, Aurora, OH). Each conventional
MRI study included at least one water sensitive sequence
either in the coronal or axial plane: a fat-suppressed fast
spin-echo (FSE) T2-weighted sequence (a TR/TE [msec] of
2,500-5,000/64-82-5, an echo train length of 6-8, a 256
× 192 matrix, a slice thickness of 6-8 mm and a 1 mm
slice gap) or a FSE inversion recovery-weighed sequence (a
TR/TE of 4,500/35, an inversion time of 155 msec, an echo
train length of 8, a 256 × 192 matrix, a slice thickness of
3-5 mm and a 1-2 mm slice gap). The axial and coronal
conventional T1-weighted images were performed without
fat suppression (a TR/TE of 500-600/14-23). The field of
view ranged from 20 to 28 cm and this was determined by
the patient’s size in order to fully include the gluteal
muscles.
T2 Mapping
The axial and coronal T2 maps without fat saturation
were obtained through the pelvic girdle using a T2-
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Fig. 1. Summary of changes on conventional MRI, T2 relaxation
mapping and clinical functional score for study group.weighted multislice, multiecho sequence to quantify the
spatial distribution of the T2 relaxation times. A nine echo
train length was utilized: TE = 9, 18,…, 99 msec, TR =
1,500 msec. The acquisition time for each T2 map was
approximately 3.5 minutes. The total imaging time for
both the conventional MRI and the T2 mapping sequences
ranged from 45 to 60 minutes. No intravenous contrast or
sedation was utilized. As the T2 values can be affected by
exercise or activity (14), the patients were requested to not
excessively ambulate or exercise for the 12 hours prior to
the MRI evaluations.
Conventional MRI Interpretation
The conventional MRI examinations were interpreted by
two radiologists (one with pediatric radiology fellowship
training and 17 years’ experience, and the other with both
pediatric and musculoskeletal radiology fellowship training
and 3 years’ experience) by consensus. Using the conven-
tional T1-weighted sequence, the gluteus muscle fatty
infiltration was assessed. Muscle inflammation was
assessed by the increased signal intensity on the fat
suppressed FSE T2-weighted images, or the FSE inversion
recovery sequence. The initial and follow-up MRI
examinations were compared to identify interval changes
Kim et al.
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Fig. 2. 9-year-old boy with Duchenne muscular dystrophy.
Conventional MRI and T2 maps obtained prior to and during 12-
month course of steroid therapy.
A. Axial T1 weighted image (TR/TE 550/14) shows very minimal
fatty infiltration within gluteus maximus muscle. Clinical functional
score was assessed as 1 (normal).
B. Follow-up axial T1 weighted image (TR/TE 600/14) shows
minimal increase of fatty infiltration (arrow) within gluteus maximus
muscle. Clinical functional score was assessed as 1 (normal). 
C, D. Color coded T2 map shows color change to higher scale
color (from red to white) within gluteal muscles (arrow in D). 
E. Histogram demonstrates statistically different distribution
between two time points. Mean T2 value for this patient increased
(from 71.2 msec on initial study to 77.3 msec on follow-up study). 
Eof the fatty infiltration and inflammation. The examina-
tions were evaluated without the radiologists being
informed about the patients’ identity.
T2 Mapping Interpretation
The axial and coronal T2 maps through the pelvic girdle
were generated. The T2 relaxation time pixel scale was
color coded for easier interpretation and comparison over
time. A region of interest (ROI) was traced by a single
radiologist around the entire right gluteus maximus muscle.
Using an institutional software program, the distribution of
the T2 relaxation time was determined in the right gluteus
maximus muscle ROI. A histogram and the mean and
standard deviation of the T2 relaxation time were
obtained. As a given patient can have different muscle
volumes at each time point, the histogram was normalized
to a muscle volume of 2,500 pixels.
Statistical Analysis
Statistical analysis was performed using SAS 
� (statistical
software version 9.1, SAS Institute, Inc., Cary, NC). For
each subject, a Chi-square test was used to assess the
change in the distribution of the histogram between the
two T2 maps generated at each imaging assessment. P
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Fig. 3. 5-year and 2-month-old boy with Duchenne muscular
dystrophy. Conventional MRI and T2 maps obtained prior to and
during 18-month course of steroid therapy.
A. Axial T1 weighted image (TR/TE 517/22) shows mild fatty
infiltration within gluteus maximus muscle. Clinical function score
was assessed as 1 (normal).
B. Follow-up axial T1 weighted image (TR/TE 517/14) shows no
interval change of fatty infiltration within gluteus maximus muscle.
Clinical functional score was assessed as 1 (normal).
C, D. Color coded T2 map shows color change to higher scale
color (from white to violet) within gluteal muscles. 
E. Histogram demonstrates statistically different distribution
between two time points. Mean T2 value for this patient increased
(from 87.2 msec on initial study to 91.3 msec on follow-up study). 
Evalues less than 0.05 were considered to be statistically
significant.
RESULTS
The changes in the CFS, the conventional MRI examina-
tions and the T2 maps are summarized in Figure 1. Before
steroid treatment, all the boys had no or minimal
weakness, which was determined by a CFS of 1 or 2.
During the course of steroid therapy, no change was
detected in the CFS of any patient. For the 11 patients,
there was a wide range of mean T2 relaxation times
obtained from the T2 maps prior to steroid therapy. The
values ranged from 56.5 msec to 125.6 msec with an
average of 79.1 msec. 
On the follow-up conventional MRI examinations, two
boys showed a subjectively judged increase of their fatty
infiltration. The other nine boys’ conventional MRI
examinations showed no change. None of the conventional
MRI examinations showed any abnormally increased signal
Kim et al.
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Fig. 4. 75-month-old boy with Duchenne muscular dystrophy.
Conventional MRI and T2 maps obtained prior to and during 12-
month course of steroid therapy.
A. Axial T1 weighted image (TR/TE 517/14) shows very minimal
fatty infiltration within gluteus maximus muscle. Clinical function
score was assessed as 1 (normal).
B. Follow-up axial T1 weighted image (TR/TE 650/14) shows no
interval change of fatty infiltration within gluteus maximus muscle.
Clinical functional score was assessed as 1 (normal). Hyperintense
T1 signal within bladder is from intravenous MRI contrast agent,
which was administrated for cardiac study that was performed
previously on same date.
C, D. Color coded T2 map shows no color change within gluteal
muscles between initial (C), and follow-up (D) examinations. 
E. Histogram demonstrates no statistically significant difference in
distribution between two time points. Mean T2 value for this patient
decreased slightly, but change was not statistically significant (from
72.4 msec on initial study to 71.1 msec on follow-up study, p value
> 0.05). 
Eon a fat suppressed FSE T2-weighted or FSE inversion
recovery sequence to suggest inflammation, on either the
initial or follow-up MRI examination. 
The two boys with increased fatty infiltration seen on
their follow-up conventional MRI showed statistically
significant different distributions of the T2 relaxation times
on the histograms between the initial and follow-up
studies. Both boys had a statistically significant rightward
shift of their histograms (p < 0.05) with an increase in the
mean T2 relaxation time (Fig. 2). 
The T2 maps from the remaining nine boys who showed
no change of muscle signal on conventional MRI showed
different distribution patterns on the histograms. Three of
the nine boys showed a statistically significant rightward
shift of the histograms (p < 0.05) between the initial and
the follow-up examinations (Fig. 3). Two of the nine boys
showed no statistically significant different distribution of
the histograms (Fig. 4). The remaining four boys showed a
statistically significant leftward shift of the histograms (p <
0.05) with a decrease of the mean T2 relaxation time (Fig.
5). 
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Fig. 5. 5-year-old boy with Duchenne muscular dystrophy.
Conventional MRI and T2 maps obtained prior to and during 16-
month course of steroid therapy.
A. Axial T1 weighted image (TR/TE 600/23) shows very minimal
fatty infiltration within gluteus maximus muscle. Clinical function
score was assessed as 1 (normal).
B. Follow-up axial T1 weighted image (TR/TE 517/14) shows no
significant interval change of fatty infiltration within gluteus
maximus muscle. Clinical functional score was assessed as 1
(normal).
C, D. Color coded T2 map shows color change from higher scale
color (red) (C) to lower scale color (yellow) within gluteal muscles
(D). 
E. Histogram demonstrates statistically significant different distribu-
tion between two time points. Mean T2 value for this patient
decreased (from 62.1 msec on initial study to 57.4 msec on follow-
up study). 
EDISCUSSION
Duchenne muscular dystrophy is an inherited disorder
that is associated with an abnormal gene located at the
Xp21 location, and this causes the absence of dystrophin.
This leads to reduced stability of muscle and the muscles
are rendered more susceptible to necrosis (1). Muscle
necrosis subsequently leads to progressive fatty infiltration,
which results in the characteristic findings of increased
signal intensity on the T1-weighted images of conventional
MRI (9). This fatty infiltration involves the gluteus
maximus and adductor muscles with relative sparing of the
sartorius, gracilis, semitendinosus and semimembranosus
muscles (9). However, the increased signal intensity, which
can be seen on the water sensitive sequences such as the
T2-weighted images with fat suppression or FSE inversion
recovery, suggests that muscle edema or inflammation
might play a role in the early phases of muscle damage
prior to the replacement of muscle tissue by fatty or
fibrotic tissue (15). The inflammatory pathway in DMD
has also been suggested in clinical studies that have
evaluated the effect of steroid therapy as a method to
stabilize the muscle fiber membranes and attenuate muscle
necrosis, and steroid therapy offers an immunosuppressive
effect with a reduction of the mononucleated cells (16-19).
T2 mapping has been less frequently used to quantita-
tively measure the inflammation or fatty infiltration that
results from diffuse muscle disease. A previous study that
used T2 mapping of the lower extremity muscles at single
time point in patients with DMD showed an increased T2
relaxation time in patients with severe muscle weakness, as
compared to the T2 relaxation time in those patients who
were less affected. Those authors suggested that the
increased T2 relaxation time resulted from the fatty
infiltration within the muscle (12, 20). Another study
utilizing T2 mapping of the thigh muscles in patients with
juvenile dermatomyositis showed an increased T2
relaxation time in patients with active disease, as
compared to those patients who were thought to be
inactive or who were normal controls. That study
suggested that an increased T2 relaxation time was the
result of inflammation (13). The increased T2 relaxation
time identified in muscles after exercise suggests that
muscle activation results in an increased water content
within the intracellular spaces (14). 
The variable therapeutic effect of steroids in patients
with DMD is well documented (21, 22). Likewise, in our
study, the mean change of the T2 relaxation time in the
boys on steroid treatment was variable, including an
increased, a stable and a decreased mean T2 relaxation
time. The increase in the mean T2 relaxation time, as was
determined by T2 mapping, was seen in five patients,
included two who also showed a subjective increase in
fatty infiltration within the gluteal muscles on conventional
MRI. This increase in the mean T2 relaxation time might
be due to increased fatty infiltration despite steroid
therapy. These findings support the natural progressive
course of DMD despite therapy. However, notwithstand-
ing the eventual outcome, it is possible that steroid therapy
might slow the progress of DMD. 
The lack of a statistically significant change of the mean
T2 relaxation time in two of the boys on therapy might
reflect the ability of steroids to diminish the natural
progression of DMD. Prior clinical studies have shown a
relatively longer steroid effect in a group of patients with
DMD and who also had the N 363S polymorphism, as
compared to a non-carrier group (22). Although none of
the patients in our study were evaluated for this specific
gene, we suggest that some boys achieved a relatively
stable disease state on steroid therapy. Kissel et al. (19)
showed a significant decrease in mononuclear cells in the
muscle biopsies from patients with DMD and who were
treated with steroids, as compared to an untreated group,
and this suggested the steroids reversed the inflammatory
changes. In four children in our study, a decrease in mean
T2 relaxation time was seen while they were on steroid
therapy. This finding might reflect a decrease in muscle
inflammation, despite that there were no identifiable
changes on conventional MRI or on clinical assessment.
Our study has several limitations. The study group size
was small and the follow-up time was limited. No patient
underwent muscle biopsy during steroid therapy to
confirm the histologic changes suggested by the T2
mapping. Furthermore, T2 mapping was not performed in
a longitudinal fashion for boys who had not undergone
treatment. Further study with longer term follow up of a
larger patient group may needed to determine the meaning
of the different changes of the T2 relaxation time after
steroid treatment in DMD patients. Future studies with
larger size cohorts might be useful to predict the response
to treatment in patients with different compounding
factors, such as the patient age at disease onset, the disease
severity and the degree of muscle inflammation before
treatment. 
We conclude that T2 mapping is a feasible quantitative
technique that can be used in the longitudinal assessment
of the muscle changes in children who are on steroid
therapy for DMD. The T2 maps generated in children who
are undergoing steroid therapy might reflect alterations in
the disease activity, which includes the changes in the
extent of inflammation and fatty infiltration even when the
conventional MRI examinations and CFSs remain stable. 
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